Press Releases

Date Title and Summary Additional Formats
Toggle Summary CHF Solutions Announces Distribution Agreement in India
EDEN PRAIRIE, Minn. , Jan. 31, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), today announced the initiation of a distribution agreement in the Indian market with Wayinia Lifesciences.  This agreement expands the company’s sales outreach in Asia , while opening new access to one of the
View HTML
Toggle Summary CHF Solutions Sponsors Breakfast Symposium on Ultrafiltration Featuring Renowned Cardiothoracic Surgeon Daniel Beckles, M.D., Ph.D., at Society of Thoracic Surgeons 55th Annual Meeting
EDEN PRAIRIE, Minn. , Jan. 24, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), today announced it will be sponsoring a breakfast symposium at the Society of Thoracic Surgeons Annual Meeting, featuring Daniel Beckles , M.D., Ph.D., on Monday, January 28, 2019 , at the Marriott Marquis in San
View HTML
Toggle Summary CHF Solutions Expands Intellectual Property Portfolio with Two New Patent Filings for Innovations to Aquadex FlexFlow® System
EDEN PRAIRIE, Minn. , Jan. 16, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced the filing of two new patent applications with the United States Patent and Trademark Office (USPTO) designed to deepen the company’s intellectual property protection for its Aquadex FlexFlow
View HTML
Toggle Summary CHF Solutions to Exhibit at Heart Failure University
EDEN PRAIRIE, Minn. , Dec. 05, 2018 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), today announced that it will be exhibiting at Heart Failure University from December 7-9, 2018 at the Los Angeles Airport Marriott , Los Angeles, Calif. “Heart Failure University is a unique venue as cardiology
View HTML
Toggle Summary CHF Solutions to Present at the 11th Annual LD Micro Main Event
CHF Solutions to Present at the 11th Annual LD Micro Main Event Eden Prairie, Minn. / ACCESSWIRE / November 28, 2018 / CHF Solutions (Nasdaq: CHFS), today announced that it will be presenting at the 11 th annual LD Micro Main Event on Wednesday, December 5 th at 7:30AM PST /10:30AM EST.
View HTML
Toggle Summary CHF Solutions Launches Educational Webinar Discussing the Benefits of Aquadex FlexFlow® Therapy Following Cardiovascular Surgery with Cardiovascular Surgeon, Daniel Beckles, M.D., Ph.D.
EDEN PRAIRIE, Minn. , Nov. 15, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS), today announces the launch of its new educational webinar featuring Daniel Beckles , M.D., Ph.D., director of Minimally Invasive Cardiothoracic Surgery at UHS Heart and Vascular Institute , Vestal, N.Y.  The
View HTML
Toggle Summary CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn. , Nov. 09, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) today announced that on November 8, 2018 , the independent directors approved four equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to four individuals entering into
View HTML
Toggle Summary CHF Solutions to Release Educational Webinar Highlighting Use of Aquadex FlexFlow® System in Post-Cardiovascular Surgery Featuring Noted Cardiovascular Surgeon, Daniel Beckles, MD, PhD
EDEN PRAIRIE, Minn. , Nov. 08, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS), today announced that it will release an educational webinar featuring the clinical use of the Aquadex FlexFlow system following cardiovascular surgery in patients who have failed diuretic therapy.  The
View HTML
Toggle Summary CHF Solutions, Inc. Announces 42% Revenue Growth for its Third Quarter and Provides Company Update
EDEN PRAIRIE, Minn. , Nov. 06, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) announced today its third quarter results for the period ended September 30 , 2018.  Highlights include: Revenue for third quarter ended September 30, 2018 increased 42 percent compared to the same period in
View HTML
Toggle Summary CHF Solutions Initiates Strategic Collaboration with Daxor Corporation to Assist in the Management of Patients with Fluid Overload
EDEN PRAIRIE, Minn. , Nov. 01, 2018 (GLOBE NEWSWIRE) -- CHF Solutions , Inc. (Nasdaq: CHFS) announced today that it has entered into a collaboration agreement with Daxor Corporation (NYSE:DXR) to explore potential synergies between the company’s Aquadex FlexFlow ® System and Daxor’s BVA-100 Blood
View HTML